Newsroom | 70840 results
Sorted by: Latest
-
Organon presentará nuevos estudios sobre acceso y valor en ISPOR 2026
JERSEY CITY, Nueva Jersey--(BUSINESS WIRE)--Organon (NYSE: OGN), una empresa sanitaria global cuya misión es ofrecer medicamentos y soluciones de gran impacto para mejorar la salud en el día a día, presentará datos sobre salud femenina, biosimilares, dermatología y neurología en ISPOR 2026, la principal conferencia científica mundial que organiza la Sociedad Internacional de Farmacoeconomía e Investigación de Resultados. La conferencia, centrada en la economía de la salud y la investigación de...
-
United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the New England Journal of Medicine has published the full results of its TETON-1 study, as well as combined analyses of its TETON-1 and TETON-2 studies, evaluating the use of nebulized Tyvaso for the treatment of IPF. The publication is available here. A summary of the publication was also presented today during a symposium at th...
-
Vir Biotechnology to Present Complete Week 96 Data from Phase 2 SOLSTICE Clinical Trial in Hepatitis Delta at the European Association for the Study of the Liver (EASL) Congress 2026
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will present data from the Phase 2 SOLSTICE trial evaluating the combination of tobevibart and elebsiran for chronic hepatitis delta at the upcoming EASL Congress 2026 in Barcelona, Spain, May 27-30, 2026. Efficacy and safety of tobevibart (VIR-3434) alone or in combination with elebsiran (VIR-2218) in participants with chronic hepatitis delta virus infection: Week 96 endpoint results from the Phas...
-
KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company presented its latest research at the Oncology Nursing Society (ONS) Congress, May 13-17. The poster at ONS was titled, “Reducing Ergonomic Strain During Subcutaneous Monoclonal Antibody Administration.” The ONS abstract evaluated nur...
-
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that the Company will participate in the following investor conference in June. On June 4, 2026, at 12:50 p.m. Eastern Time, Raj Asarpota, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City, NY. A live webcast of the fireside chat will be on th...
-
Battelle Names Katherine Palmer Inventor of the Year for Breakthroughs in Advanced Materials
COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle has named Katherine Palmer its Inventor of the Year, recognizing her exceptional contributions to translating cutting-edge materials science into real-world technologies that deliver meaningful societal impact. Palmer is widely recognized for solving complex “interface problems” that often determine whether a promising innovation succeeds outside the laboratory. Her work with carbon nanotube (CNT) materials has resulted in a robust intellectual property...
-
Astrolab Announces NASA Payloads for Upcoming Mission to the Moon
HAWTHORNE, Calif.--(BUSINESS WIRE)--Astrolab, an aerospace company building planetary rovers, today announced NASA payload customers for its first lunar mission aboard the company’s FLIP (FLEX Lunar Innovation Platform) rover. FLIP will fly aboard Astrobotic’s Griffin-1 lander, part of NASA’s Commercial Lunar Payload Services (CLPS) initiative. Griffin-1 will deliver payloads to the Moon’s south pole, advancing the Artemis campaign to return humans to the lunar surface. This mission is slated f...
-
Aspera Biomedicines Successfully Launches Second ADAR1p150 Crystallization Experiment to the International Space Station Aboard SpaceX CRS-34
SAN DIEGO--(BUSINESS WIRE)--Aspera Biomedicines launches second ADAR1p150 crystallization experiment to the ISS aboard SpaceX CRS-34, advancing oral Rebecsinib for 20+ cancers....
-
JCR Pharmaceuticals Presents Preclinical Gene Therapy Data that Demonstrate Promising Central Nervous System Uptake at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
HYOGO, Japan--(BUSINESS WIRE)--JCR announced today that it presented preclinical data from its novel platform technologies in oral and poster sessions at the ASGCT Annual Meeting....
-
Entanglement Chief Research Scientist Dr. Fred Glover Ranked #30 Worldwide in Research.com’s 2026 Best Mathematics Scientists List
MIAMI--(BUSINESS WIRE)--Entanglement, Inc., a next-generation computing and AI company advancing quantum logic, optimization, and artificial intelligence, today announced that its Chief Research Scientist, Dr. Fred Glover, has been ranked #30 worldwide and #22 in the United States in Research.com’s 2026 Best Mathematics Scientists ranking. The fifth annual edition of the ranking evaluates more than 3,500 leading researchers across the mathematical sciences using the discipline-specific D-index,...